vs
MEDIFAST INC（MED）与IMPINJ INC（PI）财务数据对比。点击上方公司名可切换其他公司
MEDIFAST INC的季度营收约是IMPINJ INC的1.0倍（$75.1M vs $74.3M），IMPINJ INC同比增速更快（-0.0% vs -36.9%），IMPINJ INC自由现金流更多（$2.2M vs $-6.6M），过去两年IMPINJ INC的营收复合增速更高（-14.9% vs -34.4%）
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
Impinj Inc.是一家美国射频识别（RFID）设备及软件提供商，成立于2000年，总部位于华盛顿州西雅图，源自加州理工学院Carver Mead与Chris Diorio的研究成果。公司主营EPC Class 1 Gen 2无源超高频RFID芯片、读写器、读写器芯片、天线，以及芯片编码、业务数据采集相关的软件应用，为各行业RFID应用提供全链路产品支持。
MED vs PI — 直观对比
营收规模更大
MED
是对方的1.0倍
$74.3M
营收增速更快
PI
高出36.9%
-36.9%
自由现金流更多
PI
多$8.9M
$-6.6M
两年增速更快
PI
近两年复合增速
-34.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.1M | $74.3M |
| 净利润 | — | $8.3M |
| 毛利率 | 69.4% | 49.1% |
| 营业利润率 | -10.4% | 30.5% |
| 净利率 | — | 11.2% |
| 营收同比 | -36.9% | -0.0% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-1.64 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEDPI
| Q1 26 | — | $74.3M | ||
| Q4 25 | $75.1M | $92.8M | ||
| Q3 25 | $89.4M | $96.1M | ||
| Q2 25 | $105.6M | $97.9M | ||
| Q1 25 | $115.7M | $74.3M | ||
| Q4 24 | $119.0M | $91.6M | ||
| Q3 24 | $140.2M | $95.2M | ||
| Q2 24 | $168.6M | $102.5M |
净利润MEDPI
| Q1 26 | — | $8.3M | ||
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-2.3M | $-12.8M | ||
| Q2 25 | $2.5M | $11.6M | ||
| Q1 25 | $-772.0K | $-8.5M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $1.1M | $221.0K | ||
| Q2 24 | $-8.2M | $10.0M |
毛利率MEDPI
| Q1 26 | — | 49.1% | ||
| Q4 25 | 69.4% | 51.8% | ||
| Q3 25 | 69.5% | 50.3% | ||
| Q2 25 | 72.6% | 57.8% | ||
| Q1 25 | 72.8% | 49.4% | ||
| Q4 24 | 74.1% | 50.5% | ||
| Q3 24 | 75.4% | 50.0% | ||
| Q2 24 | 73.2% | 56.1% |
营业利润率MEDPI
| Q1 26 | — | 30.5% | ||
| Q4 25 | -10.4% | -2.9% | ||
| Q3 25 | -4.6% | 0.7% | ||
| Q2 25 | -1.0% | 11.1% | ||
| Q1 25 | -1.1% | -12.9% | ||
| Q4 24 | 0.6% | -3.9% | ||
| Q3 24 | 1.5% | -0.8% | ||
| Q2 24 | -4.7% | 8.8% |
净利率MEDPI
| Q1 26 | — | 11.2% | ||
| Q4 25 | — | -1.2% | ||
| Q3 25 | -2.5% | -13.3% | ||
| Q2 25 | 2.3% | 11.8% | ||
| Q1 25 | -0.7% | -11.4% | ||
| Q4 24 | — | -2.9% | ||
| Q3 24 | 0.8% | 0.2% | ||
| Q2 24 | -4.8% | 9.7% |
每股收益（稀释后）MEDPI
| Q1 26 | — | $0.14 | ||
| Q4 25 | $-1.64 | $-0.02 | ||
| Q3 25 | $-0.21 | $-0.44 | ||
| Q2 25 | $0.22 | $0.39 | ||
| Q1 25 | $-0.07 | $-0.30 | ||
| Q4 24 | $0.08 | $-0.06 | ||
| Q3 24 | $0.10 | $0.01 | ||
| Q2 24 | $-0.75 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $131.8M |
| 总债务越低越好 | — | $241.5M |
| 股东权益账面价值 | $198.9M | — |
| 总资产 | $248.0M | $502.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MEDPI
| Q1 26 | — | $131.8M | ||
| Q4 25 | $167.3M | $175.3M | ||
| Q3 25 | $173.5M | $190.1M | ||
| Q2 25 | $162.7M | $193.2M | ||
| Q1 25 | $164.6M | $147.9M | ||
| Q4 24 | $162.3M | $164.7M | ||
| Q3 24 | $170.0M | $170.3M | ||
| Q2 24 | $163.5M | $220.2M |
总债务MEDPI
| Q1 26 | — | $241.5M | ||
| Q4 25 | — | $280.9M | ||
| Q3 25 | — | $280.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $283.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MEDPI
| Q1 26 | — | — | ||
| Q4 25 | $198.9M | $209.2M | ||
| Q3 25 | $214.7M | $195.0M | ||
| Q2 25 | $216.0M | $187.7M | ||
| Q1 25 | $211.0M | $160.6M | ||
| Q4 24 | $210.1M | $149.9M | ||
| Q3 24 | $207.3M | $136.1M | ||
| Q2 24 | $205.3M | $117.0M |
总资产MEDPI
| Q1 26 | — | $502.5M | ||
| Q4 25 | $248.0M | $545.2M | ||
| Q3 25 | $268.2M | $516.5M | ||
| Q2 25 | $269.3M | $508.8M | ||
| Q1 25 | $280.0M | $479.8M | ||
| Q4 24 | $284.2M | $489.1M | ||
| Q3 24 | $291.2M | $476.4M | ||
| Q2 24 | $293.5M | $446.1M |
负债/权益比MEDPI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.6M | $2.2M |
| 自由现金流率自由现金流/营收 | -8.8% | 3.0% |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.2M | $61.1M |
8季度趋势，按日历期对齐
经营现金流MEDPI
| Q1 26 | — | — | ||
| Q4 25 | $-5.3M | $15.1M | ||
| Q3 25 | $12.1M | $20.9M | ||
| Q2 25 | $-3.4M | $33.9M | ||
| Q1 25 | $3.4M | $-11.1M | ||
| Q4 24 | $-4.9M | $12.6M | ||
| Q3 24 | $9.1M | $10.1M | ||
| Q2 24 | $13.1M | $45.5M |
自由现金流MEDPI
| Q1 26 | — | $2.2M | ||
| Q4 25 | $-6.6M | $13.6M | ||
| Q3 25 | $10.8M | $18.0M | ||
| Q2 25 | $-4.8M | $27.3M | ||
| Q1 25 | $1.9M | $-13.0M | ||
| Q4 24 | $-7.2M | $8.5M | ||
| Q3 24 | $7.7M | $4.7M | ||
| Q2 24 | $11.1M | $44.1M |
自由现金流率MEDPI
| Q1 26 | — | 3.0% | ||
| Q4 25 | -8.8% | 14.7% | ||
| Q3 25 | 12.0% | 18.7% | ||
| Q2 25 | -4.5% | 27.9% | ||
| Q1 25 | 1.6% | -17.5% | ||
| Q4 24 | -6.1% | 9.3% | ||
| Q3 24 | 5.5% | 4.9% | ||
| Q2 24 | 6.6% | 43.0% |
资本支出强度MEDPI
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 1.6% | ||
| Q3 25 | 1.5% | 3.1% | ||
| Q2 25 | 1.3% | 6.7% | ||
| Q1 25 | 1.3% | 2.5% | ||
| Q4 24 | 1.9% | 4.5% | ||
| Q3 24 | 1.0% | 5.7% | ||
| Q2 24 | 1.1% | 1.3% |
现金转化率MEDPI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | 2.93× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | 45.56× | ||
| Q2 24 | — | 4.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
